Motor and non-motor fluctuations are well known sequelae of dopaminergic therapies for Parkinson’s disease (PD), particularly during the advanced stages. However, the prevalence of fluctuations early in the treatment course has been less well recognised and may be missed clinically if not specifically probed. We examined the used of a survey for this purpose. Patients to be surveyed were recruited by neurologists and geriatricians at 20 Australian centres. Patients had a diagnosis of idiopathic PD with a duration of fewer than 5 years and were considered by their treating physician to be non-fluctuating or had no change in their treatment plan in the prior 6 months. Patients, with or without assistance, completed a 19-item wearing-off quest...
: Background: Non-motor symptoms (NMS), including neuropsychiatric, sleep, autonomic, and sensory do...
Introduction: Parkinson’s Disease (PD) is the second most frequent neurodegenerative disease and dop...
Background: Both patients and physicians may choose to delay initiation of dopamine replacement ther...
In this report the usefulness of a dedicated questionnaire to detect end-of-dose wearing-off (EODWO)...
Background: Parkinson s disease (PD) is characterized by motor fluctuations through the day due to L...
BackgroundThe concerns of people with Parkinson's disease (PD) about their disease are often differe...
OBJECTIVE: Assessing the frequency of Wearing-Off (WO) in Parkinson's disease (PD) patients, and its...
Background Around 50% of PD patients experience motor fluctuations, which are often accompanied by m...
Objective: Assessing the frequency of Wearing-Off (WO) in Parkinson's disease (PD) patients, and its...
Patients with Parkinson disease are increasingly recognized to suffer from non-motor symptoms in add...
INTRODUCTION: Establishing the presence and severity of fluctuations is important in managing Parkin...
BackgroundIn patients with Parkinson’s disease (PD), sleep, mood, cognitive, autonomic, and other no...
OBJECTIVE: Recently described nonmotor fluctuations may cause disability in Parkinson's disease pati...
Background: The issue of when to start treatment in Parkinson’s disease (PD) remains controversial. ...
Background Both patients and physicians may choose to delay initiation of dopamine replacement thera...
: Background: Non-motor symptoms (NMS), including neuropsychiatric, sleep, autonomic, and sensory do...
Introduction: Parkinson’s Disease (PD) is the second most frequent neurodegenerative disease and dop...
Background: Both patients and physicians may choose to delay initiation of dopamine replacement ther...
In this report the usefulness of a dedicated questionnaire to detect end-of-dose wearing-off (EODWO)...
Background: Parkinson s disease (PD) is characterized by motor fluctuations through the day due to L...
BackgroundThe concerns of people with Parkinson's disease (PD) about their disease are often differe...
OBJECTIVE: Assessing the frequency of Wearing-Off (WO) in Parkinson's disease (PD) patients, and its...
Background Around 50% of PD patients experience motor fluctuations, which are often accompanied by m...
Objective: Assessing the frequency of Wearing-Off (WO) in Parkinson's disease (PD) patients, and its...
Patients with Parkinson disease are increasingly recognized to suffer from non-motor symptoms in add...
INTRODUCTION: Establishing the presence and severity of fluctuations is important in managing Parkin...
BackgroundIn patients with Parkinson’s disease (PD), sleep, mood, cognitive, autonomic, and other no...
OBJECTIVE: Recently described nonmotor fluctuations may cause disability in Parkinson's disease pati...
Background: The issue of when to start treatment in Parkinson’s disease (PD) remains controversial. ...
Background Both patients and physicians may choose to delay initiation of dopamine replacement thera...
: Background: Non-motor symptoms (NMS), including neuropsychiatric, sleep, autonomic, and sensory do...
Introduction: Parkinson’s Disease (PD) is the second most frequent neurodegenerative disease and dop...
Background: Both patients and physicians may choose to delay initiation of dopamine replacement ther...